On appeal, Amgen argued inter alia, that the embodiments in the patent are structurally representative for the purpose of fulfilling the written description requirement CAFC disagree. Supreme Court assessed if CAFC applied a heightened enablement standard to genus claims.
The Supreme Court heard oral argument in Amgen v. Sanofi last week in an extended session with argument from the parties and the U.S. government. Petitioner was represented by Jeffrey.
The oral arguments at the Supreme Court in Amgen v. Sanofi did not make the ultimate decision clear but did clarify many of the likely issues to be addressed.
The Supreme Court's decision to grant certiorari in Amgen v. Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure.
The Supreme Court's decision to grant certiorari in Amgen v. Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure.